Categories: CancerNews

From the Margins: Gilead’s Book Uniquely Captures What It’s Like To Be Marginalized by Disease

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

NORTHAMPTON, MA / ACCESSWIRE / January 30, 2024 / Gilead Sciences – The personal journeys of six people in the United Kingdom living with HIV, hepatitis C and cancer – and the challenges they face due to stigma and health inequities – come together in the form of a new, intentionally difficult-to-read book from Gilead. Entitled “From the Margins,” each person’s experience is deliberately written around the margins of the book in order to raise awareness of what it feels like to live on the periphery of society with a chronic or life-threatening disease.

“I had one foot in my cancer patient space and the other in my LGBTQ+ space,” reads an excerpt from one of the participants, named Stewart. “But there was no space where I could talk about both those things and bring them close to each other.”

Gilead teamed up with David Olusoga, a British historian and professor, to put the book together. “Throughout history and to this day, there are many people pushed to the margins of society where illness intertwines with social class, race, ethnicity, sexuality and poverty,” he says. “They shouldn’t have to take it upon themselves to overcome societies prejudices and inequalities.”

The book was published last September, and its unique format and important messages have earned significant media coverage and interest among the global patient and medical community.

The work is part of Gilead’s larger efforts to spotlight and address stigma, discrimination and other barriers to wellbeing and care; and ultimately, to improve health equity.

To read From the Margins, download a copy here.

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.

Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com

SOURCE: Gilead Sciences

View the original press release on accesswire.com

Staff

Recent Posts

MGI Tech Unveils Next-Generation Automation Portfolio at SLAS Europe 2025 in Germany

HAMBURG, Germany, May 21, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company dedicated to…

2 hours ago

Lam Research Corporation Declares Quarterly Dividend

FREMONT, Calif., May 21, 2025 /PRNewswire/ -- Lam Research Corporation (Nasdaq: LRCX) today announced that…

8 hours ago

Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer

BOSTON, May 21, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA, "Ginkgo" or the "Company"), which is…

8 hours ago

GRAIL to Present at Jefferies Global Healthcare Conference 2025

MENLO PARK, Calif., May 21, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company…

8 hours ago

Reshoring Revolution: Manufacturing’s Homecoming Poised to Unleash Economic Transformation

SAN DIEGO, May 21, 2025 /PRNewswire/ -- Flexible Assembly Systems Inc today announced that a…

8 hours ago

SHINE Announces Two Strategic Appointments to Advance Fusion Technology and Market Expansion

Healthcare technology leader Dr. Gregory Sorensen joins Board of Directors; Defense expert Col. (Ret.) Gregory…

8 hours ago